Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

In market activity today, shares of Nervgen Pharma Corp opened at $2.38 and closed at $2.32. Intraday prices ranged from $2.27 to $2.39.

Shares dipped -2.11% from the previous day's close of $2.37.

Today across North America, the TSX Composite closed -0.27% at 21639.10, the S&P 500 closed 0.23% at 5433.74, the Dow Jones Industrial Average closed -0.17% at 38647.10 and the Nasdaq Composite closed 0.34% at 17667.56.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 73,111 on 137 total trades. On average, Nervgen Pharma Corp has traded 214,342 shares over the last 5-days and 91,689 year-to-date.

The TSX-V market on the whole today saw 1,220 price advancers against 4,042 declines and 94 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have advanced 35.67 percent in the last 12 months, while they have dipped -14.07% year-to-date.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $165.73 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..